These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15592965)

  • 21. [Chemotherapy of patients with colorectal carcinoma].
    Punt CJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New oncolytic agents and immunomodulators and their application].
    Mulder NH
    Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1438-40. PubMed ID: 16010953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
    Venook AP
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of genomic markers in colorectal cancer treatment.
    Allen WL; Johnston PG
    J Clin Oncol; 2005 Jul; 23(20):4545-52. PubMed ID: 16002846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developments in combination chemotherapy for colorectal cancer.
    Goetz MP; Grothey A
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of advanced colorectal cancer in the elderly.
    Bruce C; Köhne CH; Audisio RA
    Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S84-7. PubMed ID: 18006266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy for colorectal cancer.
    Goyle S; Maraveyas A
    Dig Surg; 2005; 22(6):401-14. PubMed ID: 16479107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced colorectal cancer: current treatment and nursing management with economic considerations.
    Viale PH; Fung A; Zitella L
    Clin J Oncol Nurs; 2005 Oct; 9(5):541-52. PubMed ID: 16235581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New perspectives in predicting response to chemotherapy in colorectal cancer].
    Sempere L; Jover R
    Gastroenterol Hepatol; 2008 Nov; 31(9):580-6. PubMed ID: 19091247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
    Reddy SK; Morse MA; Hurwitz HI; Bendell JC; Gan TJ; Hill SE; Clary BM
    J Am Coll Surg; 2008 Jan; 206(1):96-106. PubMed ID: 18155574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?].
    Honecker F; Wedding U; Kolb G; Bokemeyer C
    Onkologie; 2001 Feb; 24(1):87-94. PubMed ID: 11441288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second-line therapy in colorectal cancer.
    Berlin J
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):21-6. PubMed ID: 11204658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line treatment strategies to improve survival in patients with advanced colorectal cancer.
    Gill S; Goldberg RM
    Drugs; 2004; 64(1):27-44. PubMed ID: 14723557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of new agents in the treatment of colorectal cancer.
    Köhne CH; Bruce C; Folprecht G; Audisio R
    Surg Oncol; 2004; 13(2-3):75-81. PubMed ID: 15572089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing management and survival in patients with stage IV colorectal cancer.
    Platell C; Ng S; O'bichere A; Tebbutt N
    Dis Colon Rectum; 2011 Feb; 54(2):214-9. PubMed ID: 21228671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapies, new directions: advances in the systemic treatment of metastatic colorectal cancer.
    Holen KD; Saltz LB
    Lancet Oncol; 2001 May; 2(5):290-7. PubMed ID: 11905784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer.
    Bhushan S; McLeod H; Walko CM
    Clin Colorectal Cancer; 2009 Jan; 8(1):15-21. PubMed ID: 19203892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic advances in the management of metastatic colorectal cancer.
    Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.